<unk>  also known as V941 is a cancer vaccine candidate developed by Moderna. It is a tetravalent vaccine that targets G12D, G12V, G13D or G12C driver mutations in the KRAS gene. It is currently being evaluated for the treatment of either non-small cell lung cancer, colorectal cancers with microsatellite instability, or pancreatic adenocarcinoma, all with confirmed KRAS driver mutations.
MRNA-5671
SOS box
CccDNA
Rc-o319
TRNA 
SV40 large T antigen
Mir-636 microRNA precursor family
Mir-590 microRNA precursor family